Relating to a prescription drug purchasing pool for certain health benefit plan issuers and employers.
Summary
HB 1464 would require the Texas Health and Human Services Commission to create a prescription drug purchasing pool for certain health benefit plan issuers and employers. The pool would allow participating insurers, public employers, and qualifying self-insured private employers to buy prescription drugs for employees, dependents, and retirees at discounted rates or under terms negotiated by the commission. The bill also authorizes the commission to negotiate optional stop-loss coverage for participants and allows multiple participants to jointly purchase drugs through the pool.
The bill defines eligible participants broadly to include health benefit plan issuers, political subdivisions such as counties, cities, school districts, university systems, institutions of higher education, quasi-public agencies, and self-insured private employers doing business in Texas. It directs the executive commissioner of HHSC to adopt rules governing eligibility, enrollment, contributions, participation periods, and disenrollment. The bill specifies that the pool is not a risk pool and that each participant remains responsible for paying claims or prescription drug costs under its own coverage arrangements. It takes effect September 1, 2025.
Impact
HB 1464 would add a new Chapter 446 to the Texas Health and Safety Code and place HHSC in charge of establishing and administering the prescription drug purchasing pool. It would create a new state-administered purchasing mechanism for prescription drugs, but it would not change underlying benefit obligations or create a shared claims-risk arrangement. The bill also clarifies that joint purchasing under the pool is not a multiple employer welfare arrangement under the Insurance Code, which may reduce regulatory uncertainty for participating employers and issuers.
Sentiment
The available legislative record suggests generally favorable or at least noncontroversial treatment of the bill, as it advanced out of the House Insurance Committee and was reported to Calendars without any recorded votes or committee testimony in the provided materials. The bill’s structure indicates a policy goal of lowering prescription drug costs through collective purchasing power, which is typically framed as a cost-saving and administrative-efficiency measure for public and private employers and health plan issuers.
Contention
The main points of potential contention are likely to center on the scope of HHSC’s authority, the administrative burden of creating and running the pool, and whether the arrangement meaningfully lowers costs without shifting risk or liability. Employers and health plan issuers may differ on participation terms, contribution methods, and the value of optional stop-loss coverage. Because the bill excludes the pool from being treated as a risk pool or multiple employer welfare arrangement, stakeholders concerned about insurance regulation, liability, or market effects may scrutinize those provisions, though no specific opposition is reflected in the provided discussion or vote history.
Establishes a state-run prescription drug purchasing pool, available for participation by nonstate public employers, private employers, and health insurance carriers, to maximize the value of drug discounts available to participants.
Establishes a state-run prescription drug purchasing pool, available for participation by nonstate public employers, private employers, and health insurance carriers, to maximize the value of drug discounts available to participants.
Prohibits pre-approval or precertification of medical tests, procedures and prescription drugs covered under health benefits or prescription drug benefits plans.
Prohibits pre-approval or precertification of medical tests, procedures and prescription drugs covered under health benefits or prescription drug benefits plans.
Prohibits pre-approval or precertification of cancer treatments, tests, procedures and prescription drugs covered under health benefits or prescription drug benefits plans.
An Act amending the act of May 13, 2008 (P.L.139, No.14), known as the Cancer Drug Repository Program Act, further providing for title and short title of act, for definitions, for establishment, for r . . .estocking and dispensing of cancer drugs, for storage, distribution and fees and for immunity; providing for annual report, for list of approved participating pharmacies and for limitations; further providing for regulations; and imposing duties on the State Board of Pharmacy.
Establishes a state-run prescription drug purchasing pool, available for participation by nonstate public employers, private employers, and health insurance carriers, to maximize the value of drug discounts available to participants.
Establishes a state-run prescription drug purchasing pool, available for participation by nonstate public employers, private employers, and health insurance carriers, to maximize the value of drug discounts available to participants.